William Gangi is Vice President, Portfolio and Program Management, at Aura. Mr. Gangi bring more than 25 years of drug development program management experience across all phases of development. He most recently served as Senior Director, Program Lead/Manager, at Kiniska Pharmaceuticals and as Director and Due Diligence Program Manager at Shire Pharmaceuticals. Before Shire, Mr. Gangi held roles of increasing responsibility at Amgen focused on program management and strategic operations of the Company’s early-, mid- and late-stage and marketed oncology portfolio. Earlier in his career, Mr. Gangi was a Pharmaceutical Consultant at Deloitte Consulting and a Project Manager at Bispecifics Technologies Corporation. He received his MBA from the Kellogg School of Management at Northwestern University and a M.S. and B.S. in biology from St. John’s University.